<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04594577</url>
  </required_header>
  <id_info>
    <org_study_id>Fluispotter-01</org_study_id>
    <secondary_id>EUDAMED CIV-20-10-038466</secondary_id>
    <secondary_id>Journal no. 2020100544</secondary_id>
    <secondary_id>Journal no. H-20068538</secondary_id>
    <nct_id>NCT04594577</nct_id>
  </id_info>
  <brief_title>Clinical Validation of the Fluispotter System for Serial Sampling of Venous Dried Blood Spots</brief_title>
  <official_title>The Clinical Validation of Fluispotter®, a Novel Automated Body-worn System for Serial Sampling of Venous Dried Blood Spots</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fluisense ApS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dantrials Aps</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Fluisense ApS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, single-centre, non-comparative, non-randomized, open label, clinical&#xD;
      investigation of the clinical performance and safety of Fluispotter. The main aim is to&#xD;
      validate the clinical performance and safety of the body-worn Fluispotter system used for&#xD;
      automated extraction, collection and storage of 20 dried venous dried blood spot samples of&#xD;
      10 µl over the course of 20 hours.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 27, 2021</start_date>
  <completion_date type="Actual">March 22, 2021</completion_date>
  <primary_completion_date type="Actual">March 22, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of samplings</measure>
    <time_frame>20 hours</time_frame>
    <description>Number of successful samplings over a 20-hour period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical safety, safety reporting</measure>
    <time_frame>8 ± 2 days</time_frame>
    <description>Frequency and severity of adverse events (AEs), adverse device effects (ADEs) and device deficiencies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical safety, systemic effects</measure>
    <time_frame>24 hours</time_frame>
    <description>Clinical haematology and biochemistry tests before and after 20-hour sampling session</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical performance</measure>
    <time_frame>20 hours</time_frame>
    <description>Details of technical performance (yes, no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure</measure>
    <time_frame>Approximately 60 minutes and 24 hours</time_frame>
    <description>Details of procedure, including duration of procedure steps (minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability: User experience based on questionnaire</measure>
    <time_frame>24 hours</time_frame>
    <description>Usability questions related to use and disposal of system (1= Strongly disagree, 2 = Mildly disagree, 3 = Indifferent, 4 = Mildly agree, 5 = Mildly agree)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability: Subject experience based on questionnaire</measure>
    <time_frame>24 hours and 8 ± 2 days</time_frame>
    <description>Usability questions related to pain and disturbance ((VAS) scale straight horizontal line of fixed length 10 cm)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Blood Sampling Procedure</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Fluispotter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fluispotter automated blood sampling system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fluispotter</intervention_name>
    <description>Fluispotter automated blood sampling system applied for venous blood sampling of 20 10 μL samples in a 20 hours sampling session.</description>
    <arm_group_label>Fluispotter</arm_group_label>
    <other_name>Fluispotter Control System, Fluispotter Cartridge, Fluispotter Catheter 45</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female&#xD;
&#xD;
          -  Age ≥ 18&#xD;
&#xD;
          -  Able to understand verbal and written instructions in Danish&#xD;
&#xD;
          -  Able and willing to sign and date the informed written consent form and letter of&#xD;
             authority&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently participating in a clinical trial evaluating drugs or medical devices&#xD;
&#xD;
          -  Known history of coagulation disorders&#xD;
&#xD;
          -  Currently taking regular medication (contraceptives, hormonal replacement therapy and&#xD;
             antihistamines exempted)&#xD;
&#xD;
          -  Regular smoking or use of nicotine products&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Haematocrit &lt; 38% (male); &lt; 33% (female)&#xD;
&#xD;
          -  Haematocrit &gt; 52% (male); &gt; 48% (female)&#xD;
&#xD;
          -  C-reactive protein (CRP) &gt; 10 mg/dL&#xD;
&#xD;
          -  Body Mass Index (BMI) &gt; 30&#xD;
&#xD;
          -  Known allergies or hypersensitivity to flushing solution constituents&#xD;
&#xD;
          -  Other factors which in the opinion of the investigator would interfere with the&#xD;
             ability to provide informed consent, comply with study procedures/instructions, or&#xD;
             possibly confound the interpretation of the study results or put the subject at undue&#xD;
             risk&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jesper Sonne, MD, DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dantrials Aps</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>DanTrials ApS</name>
      <address>
        <city>Copenhagen</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>October 14, 2020</study_first_submitted>
  <study_first_submitted_qc>October 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2020</study_first_posted>
  <last_update_submitted>May 26, 2021</last_update_submitted>
  <last_update_submitted_qc>May 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

